Ranbaxy Files Three Antiretroviral ANDAs Under Expedited Review Process

The generic firm's versions of zidovudine, lamivudine and nevirapine were filed under the President's Emergency Plan for AIDS Relief. The products will only be sold in the developing world; Ranbaxy plans to file a total of 15 ANDAs under the plan by the second quarter.